Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Import Crackdown Escalates With DoJ Suit Vs. Canadian Pharmacy Site

Executive Summary

FDA is escalating its enforcement against drug reimportation through a Department of Justice suit against a Canadian pharmacy operation

You may also be interested in...



Canadian Rx Import Business Is Illegal, Court Finds In Granting FDA Injunction

Rx Depot will be required to send a letter to customers indicating that the firm has violated the law under a Tulsa federal court order

Canadian Rx Import Business Is Illegal, Court Finds In Granting FDA Injunction

Rx Depot will be required to send a letter to customers indicating that the firm has violated the law under a Tulsa federal court order

FDA Steps Up Campaign Against Rx Imports; Bill “Technically” Flawed

Pending federal legislation to allow importation of prescription drugs from Canada would create unworkable conflicts with state pharmacy laws, FDA Commissioner Mark McClellan told the National Association of Boards of Pharmacy legislative conference Sept. 14 in Washington, D.C

Related Content

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel